AimVion A/S: Financial statements 2017
CVR: 37120618
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
AimVion A/S (CVR 37120618) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -1,081,125 and a net result of DKK -1,374,108. Equity in the 2017 report amounted to DKK 2,064,547. The solvency ratio was 98.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,081,125
- Profit/Loss
- DKK -1,374,108
- Equity
- DKK 2,064,547
- Total Assets
- DKK 2,099,761
- Employees
- 1
Official annual report
Keep an eye on AimVion A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
AimVion A/S has published its interim report for the period September 21, 2015 – December 31, 2016.
On May 17, 2017, the company changed its name from StemGuard A/S to AimVion A/S.
As of April 18, 2017, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of AimVion A/S.
As of April 18, 2017, AROS STATSAUTORISEREDE REVISORER I/S has stepped down as auditor of AimVion A/S.
About AimVion A/S
AimVion A/S was a Danish company of the type Aktieselskab based in Aarhus C, founded in 2015. The company has been dissolved on 28 June 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named StemGuard A/S and StemGuard ApS. The company has 1 employee (2020). In 2021, the company reported a gross profit of DKK -2,119,220 and a net result of DKK -1,734,826 compared with DKK -2,143,862 the year before. Equity in the 2021 report amounted to DKK 962,455.